Future Financial Wealth Managment LLC Decreases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Future Financial Wealth Managment LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 47.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 561 shares of the healthcare conglomerate’s stock after selling 500 shares during the period. Future Financial Wealth Managment LLC’s holdings in UnitedHealth Group were worth $284,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group in the 3rd quarter worth $27,000. Global Wealth Strategies & Associates boosted its holdings in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the last quarter. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the third quarter valued at approximately $32,000. Quarry LP raised its stake in UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares during the last quarter. Finally, RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent research reports. Cantor Fitzgerald boosted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft lifted their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Barclays lifted their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a report on Wednesday, November 27th. Finally, TD Cowen boosted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $626.79.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $23.97 during mid-day trading on Monday, reaching $544.66. The company had a trading volume of 4,051,743 shares, compared to its average volume of 4,160,355. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The stock’s 50-day simple moving average is $555.25 and its 200-day simple moving average is $562.50. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market capitalization of $501.24 billion, a P/E ratio of 35.48, a P/E/G ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the company posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.